As unregulated peptides grow in popularity, doctors warn of unknown risks ABC7 San Francisco The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Buy TB500 BPC 157 Blend Ireland PharmaLabGlobal The Injury That Won't QuitCan Peptides Help? Albano Clinic BPC 157: Miracle Healing Peptide or Hidden Danger? Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed